http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010073181-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate | 1999-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010073181-A |
| titleOfInvention | Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides |
| abstract | It is an object of the present invention to discover new effects of natriuretic peptides in the field of ophthalmology. The present invention provides eye drops for promoting lacrimal secretion or treating keratoconjunctival disorders containing a natriuretic peptide as an active ingredient. Natriuretic peptides are atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and type C natriuretic peptide (CNP). Typical examples of keratoconjunctival disorders include dry eye, corneal sores and corneal ulcers. |
| priorityDate | 1998-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.